Data Foundry

Drug recalls 2014

Ranitidine Tablets USP — Class II drug recall D-1229-2014

Terminated recall by Glenmark Generics Inc., USA, reported 2014-04-16, distributed nationwide. Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identif

Recall numberD-1229-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmGlenmark Generics Inc., USA, Mahwah, NJ, United States
Recall initiated2014-03-18
Classified2014-04-09
Reported by FDA2014-04-16
Terminated2015-01-21
DistributedNationwide (US)
Quantity2,904 bottles
Reason classesforeign material
UPC / GTIN / UDI-DI00368462248058
NDC68462-0248-05
Lot numbers10/14, 12AN118A

Product

Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited, Unit-II R.S. No 32 33 & 34, Shasun Road, Periyakalapet, Puducherry, - 605 014, India; Manufactured for: Glenmark Generics Inc, USA, Mahwah, NJ 07430, UPC 3 68462 24805 8, NDC 68462-248-05.

Reason for recall

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1229-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.